Amélie Boespflug

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers

Conan G. Kinsey, Soledad A. Camolotto, Amélie Boespflug et al. · Nature Medicine · 2019 · 631 citations · Full text

Ras-driven Cancers, Cell Autophagy, Mitophagy +11

<scp>ZEB</scp> 1‐mediated melanoma cell plasticity enhances resistance to <scp>MAPK</scp> inhibitors

Geoffrey Richard, Stéphane Dalle, Marie‐Ambre Monet et al. · EMBO Molecular Medicine · 2016 · 124 citations · Full text

Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting

Pauline Corbaux, Denis Maillet, Amélie Boespflug et al. · European Journal of Cancer · 2019 · 80 citations · Full text

Similar Outcomes, Geriatric Oncology, Oncology +11

Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors

Denis Maillet, Pauline Corbaux, Jean‐Jacques Stelmes et al. · European Journal of Cancer · 2020 · 69 citations

Autoimmune Disease, Medicine, Immune Checkpoint Inhibitors +11

Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma

Marie Perier‐Muzet, Elodie Gatt, Julien Péron et al. · JAMA Dermatology · 2017 · 66 citations · Full text